Characterization of Enhanced Behavioral Responses tol-DOPA Following Repeated Administration in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

By Henry B.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 151, Iss. 2, 1998-06 ,pp. : 334-342

Elsevier

Access to resources Recommend Favorite

Antiparkinsonian and Behavioral Effects of Inactivation of the Substantia Nigra Pars Reticulata in Hemiparkinsonian Primates

By Wichmann T.   Kliem M.A.   DeLong M.R.  

Experimental Neurology, Vol. 167, Iss. 2, 2001-02 ,pp. : 410-424

Elsevier

Access to resources Recommend Favorite

Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients

By Prescott I. A.   Dostrovsky J. O.   Moro E.   Hodaie M.   Lozano A. M.   Hutchison W. D.  

Brain, Vol. 132, Iss. 2, 2009-02 ,pp. : 309-318

Oxford University Press

Access to resources Recommend Favorite

Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra

By Martorana A.   Fusco F.R.   D'Angelo V.   Sancesario G.   Bernardi G.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 311-319

Elsevier

Access to resources Recommend Favorite

Enhancement of the Behavioral Response to Apomorphine Administration Following Repeated Treatment in the 6-Hydroxydopamine-Lesioned Rat Is Temporally Correlated with a Rise in Striatal Preproenkephalin-B, but Not Preproenkephalin-A, Gene Expression

By Duty S.   Brotchie J.M.  

Experimental Neurology, Vol. 144, Iss. 2, 1997-04 ,pp. : 423-432

Elsevier

Access to resources Recommend Favorite